mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.001 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.002 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.002 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |